F-box proteins in epigenetic regulation of cancer

Jia Shen; Charles Spruck

doi:10.18632/oncotarget.22469

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

F-box proteins in epigenetic regulation of cancer

Jia Shen _ and Charles Spruck

PDF | HTML | How to cite

Oncotarget. 2017; 8:110650-110655. https://doi.org/10.18632/oncotarget.22469

Metrics: PDF 1798 views | HTML 3088 views | ?

Abstract

Jia Shen1 and Charles Spruck1

1Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, San Diego, California, USA

Correspondence to:

Jia Shen, email: [email protected]

Charles Spruck, email: [email protected]

Keywords: F-box protein; SCF; E3 ubiquitin ligase; epigenetics; cancer

Received: September 12, 2017 Accepted: October 25, 2017 Published: November 16, 2017

ABSTRACT

Epigenetic abnormalities are now realized as important as genetic alterations in contributing to the initiation and progression of cancer. Recent advancements in the cancer epigenetics field have identified extensive alterations of the epigenetic network in human cancers, including histone modifications and DNA methylation. F-box proteins, the substrate receptors of SCF (SKP1-Cullin1-F-box protein) E3 ubiquitin ligases, can directly and indirectly affect the balance of epigenetic regulation. In this brief review, we discuss our current understanding of F-box proteins in cellular epigenetic regulation and how dysregulation of these processes contribute to cancer development.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22469

Publication Alerts

Oncoscience

Post-Publication Promotion

Reviews:

F-box proteins in epigenetic regulation of cancer

Abstract